Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

2 papers

Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

Chittaranjan Andrade

Researchers reviewed many studies on ketamine for depression and found that we still do not have firm answers about the best dose, how fast to give it, which way to give it, how long to treat, or how often to give treatments. Most studies used 0.5 mg/kg given over about…

Anesthesia and Sedative Agents Electroconvulsive Therapy Studies Treatment of Major Depression

Ketamine treatment for refractory anxiety: A systematic review

Jamie L. Tully, Amelia D. Dahlén, Connor J. Haggarty, Helgi B. Schiöth, Samantha J. Brooks

This systematic review looked at clinical studies of ketamine for people whose anxiety did not get better with standard treatments. The authors found early signs that single doses of ketamine can reduce anxiety quickly, but the benefits are often temporary (typically lasting days to about a week). The existing studies…

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Treatment of Major Depression Tryptophan and brain disorders
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.